Back to GetFilings.com




UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20459

 


 

FORM 10-Q

 

(Mark One)

 

x   QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended March 31, 2003

 

OR

 

¨   TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the Transition period from                                                   to                                                  

 

Commission file number 1-14151

 

CLC HEALTHCARE, INC.

(Exact name of Registrant as specified in its charter)

 

Nevada

 

91-1895305

(State or other jurisdiction of

 

(I.R.S. Employer

incorporation or organization)

 

Identification No)

 

7610 N. Stemmons Freeway, Suite 500

Dallas, Texas 75247

(Address of principal executive offices)

 

(214) 905-9033

(Registrant’s telephone number, including area code)

 

Indicate by check mark whether Registrant (1) has filed all reports to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  ¨

 

Indicate by check mark whether the Company is an accelerated filer. Yes  ¨    No  x

 

Shares of Registrant’s common stock, $.01 par value, outstanding at May 11, 2003 – 2,132,826 (excludes Treasury Shares of 1,203,056).

 



CLC HEALTHCARE, INC.

 

FORM 10-Q

 

March 31, 2003

 

INDEX

 

         

Page


PART I—Financial Information

    

Item 1.

  

Financial Statements

    
    

     Consolidated Balance Sheets

  

3

    

     Consolidated Statements of Operations

  

4

    

     Consolidated Statements of Cash Flows

  

5

    

     Notes to Consolidated Financial Statements

  

6

Item 2.

  

Management’s Discussion and Analysis of Financial Condition and Results of Operations

  

12

Item 3.

  

Quantitative And Qualitative Disclosures About Market Risk

  

14

Item 4.

  

Controls and Procedures

  

14

Part II—Other Information

    

Item 5.

  

Other Information

    

Item 6.

  

Exhibits and Reports on Form 8-K

  

15

 

2


CLC HEALTHCARE, INC.

 

CONSOLIDATED BALANCE SHEETS

(Unaudited)

 

    

March 31,

2003


    

December 31,

2002


 
    

(In thousands, except share and per share amounts)

 

ASSETS

                 

Current Assets:

                 

Cash and cash equivalents

  

$

1,692

 

  

$

1,796

 

Accounts receivable, net of allowance for doubtful accounts: 2003—$4,367; 2002 – $4,371

  

 

7,210

 

  

 

7,774

 

Prepaid expenses and other current assets

  

 

4,122

 

  

 

1,078

 

    


  


Total current assets

  

 

13,024

 

  

 

10,648

 

Property and Equipment:

                 

Land

  

 

100

 

  

 

100

 

Buildings and improvements

  

 

1,576

 

  

 

1,576

 

Furniture, fixtures and equipment

  

 

4,342

 

  

 

4,312

 

Accumulated depreciation

  

 

(2,327

)

  

 

(1,484

)

    


  


Property and equipment, net

  

 

3,691

 

  

 

4,504

 

Other Assets:

                 

Investment in unconsolidated affiliate

  

 

3,095

 

  

 

2,843

 

Debt securities

  

 

1,417

 

  

 

1,410

 

Other assets

  

 

217

 

  

 

217

 

    


  


Total other assets

  

 

4,729

 

  

 

4,470

 

    


  


Total assets

  

$

21,444

 

  

$

19,622

 

    


  


LIABILITIES AND STOCKHOLDERS’ DEFICIT

                 

Current Liabilities:

                 

Accounts payable

  

$

7,187

 

  

$

7,574

 

Accrued salaries and benefits

  

 

2,766

 

  

 

2,822

 

Resident trust fund balances

  

 

485

 

  

 

516

 

Current portion of mortgage loans payable

  

 

43

 

  

 

41

 

Accrued rent payable to LTC

  

 

2,400

 

  

 

2,400

 

Current portion of accrued self insurance risk

  

 

4,152

 

  

 

2,443

 

Other accrued liabilities

  

 

8,677

 

  

 

5,000

 

    


  


Total current liabilities

  

 

25,710

 

  

 

20,796

 

Deferred rent to LTC

  

 

2,069

 

  

 

1,917

 

Accrued self insurance risk, less current portion

  

 

10,156

 

  

 

10,156

 

Mortgage loans payable, less current portion

  

 

1,098

 

  

 

1,109

 

Notes payable— Medicare

  

 

—  

 

  

 

149

 

Notes payable— LTC

  

 

7,936

 

  

 

7,850

 

Line of credit from LTC

  

 

6,759

 

  

 

5,813

 

    


  


Total liabilities

  

 

53,728

 

  

 

47,790

 

Commitments and Contingencies

                 

Stockholders’ Deficit:

                 

Preferred stock $0.01 par value; 10,000,000 shares authorized

  

 

—  

 

  

 

—  

 

Common stock $0.01 par value; 40,000,000 shares authorized;
shares issued: 2003—3,335,882; 2002—3,335,882

  

 

33

 

  

 

33

 

Capital in excess of par value

  

 

10,224

 

  

 

10,224

 

Treasury stock: shares 2003—1,193,056; 2002—1,190,056

  

 

(2,656

)

  

 

(2,654

)

Unearned stock compensation

  

 

(112

)

  

 

(130

)

Accumulated deficit

  

 

(39,387

)

  

 

(35,259

)

Accumulated comprehensive loss

  

 

(386

)

  

 

(382

)

    


  


Total stockholders’ deficit

  

 

(32,284

)

  

 

(28,168

)

    


  


Total liabilities and stockholders’ deficit

  

$

21,444

 

  

$

19,622

 

    


  


 

See accompanying notes

 

 

3


CLC HEALTHCARE, INC.

 

CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

 

    

Three Months Ended
March 31,


 
    

2003


    

2002


 
    

(In thousands, except share and
per share amounts)

 

Revenues:

                 

Net resident revenue

  

$

21,580

 

  

$

22,308

 

Interest and other income

  

 

233

 

  

 

328

 

    


  


Total revenues

  

 

21,813

 

  

 

22,636

 

Costs and Expenses:

                 

Salaries and benefits

  

 

16,697

 

  

 

16,776

 

Supplies

  

 

2,472

 

  

 

2,544

 

Rent—LTC

  

 

819

 

  

 

763

 

Interest on mortgages payable

  

 

36

 

  

 

37

 

Interest on notes payable to LTC

  

 

127

 

  

 

121

 

Interest expense on line of credit from LTC

  

 

147

 

  

 

132

 

Depreciation

  

 

165

 

  

 

154

 

Provision for bad debts

  

 

221

 

  

 

197

 

Impairment charge

  

 

677

 

  

 

—  

 

Insurance expense

  

 

1,813

 

  

 

1,039

 

Other operating and administrative

  

 

3,019

 

  

 

2,874

 

    


  


Total expenses

  

 

26,193

 

  

 

24,637

 

    


  


Operating Loss

  

 

(4,380

)

  

 

(2,001

)

Equity and earnings from investment in unconsolidated affiliate

  

 

253

 

  

 

(301

)

    


  


Loss before provision for state income taxes

  

 

(4,127

)

  

 

(2,302

)

Provision for income taxes

  

 

—  

 

  

 

125

 

    


  


Net loss

  

$

(4,127

)

  

$

(2,427

)

    


  


Weighted Average Shares Outstanding:

  

 

2,143,359

 

  

 

2,139,826

 

    


  


Basic and Diluted Net Loss Per Share:

  

$

(1.93

)

  

$

(1.13

)

    


  


Comprehensive loss:

                 

Net loss

  

$

(4,127

)

  

$

(2,427

)

Unrealized loss on available-for-sale debt securities

  

 

(4

)

  

 

(3

)

    


  


Total comprehensive loss

  

$

(4,131

)

  

$

(2,430

)

    


  


 

See accompanying notes

 

 

4


CLC HEALTHCARE, INC.

 

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

 

    

Three Months Ended March 31,


 
    

2003


    

2002


 
    

(In thousands)

 

OPERATING ACTIVITIES:

                 

Net loss

  

$

(4,127

)

  

$

(2,427

)

Adjustments to reconcile net loss to net cash (used in) and provided by operating activities:

                 

Depreciation

  

 

165

 

  

 

154

 

Non-cash impairment charge

  

 

677

 

  

 

—  

 

Gain (loss) on investment in unconsolidated affiliate

  

 

(253

)

  

 

301

 

Other non-cash items

  

 

(11

)

  

 

(10

)

Changes in assets and liabilities:

                 

Decrease in accounts receivable, net

  

 

564

 

  

 

862

 

Increase in prepaid expenses and other assets

  

 

(3,043

)

  

 

(1,059

)

(Decrease) increase in accounts payable

  

 

(418

)

  

 

201

 

(Decrease) increase in accrued salaries and benefits

  

 

(55

)

  

 

121

 

Increase in accrued self insurance risk

  

 

1,709

 

  

 

616

 

Increase in accrued and deferred rent

  

 

153

 

  

 

763

 

(Decrease) increase in accrued interest payable

  

 

(91

)

  

 

213

 

Increase in other liabilities

  

 

3,614

 

  

 

617

 

    


  


Net cash (used in) provided by operating activities

  

 

(1,116

)

  

 

352

 

INVESTING ACTIVITIES:

                 

Property and equipment additions

  

 

(29

)

  

 

(263

)

    


  


Net cash used in investing activities

  

 

(29

)

  

 

(263

)

    


  


FINANCING ACTIVITIES:

                 

Advances under line of credit from LTC

  

 

950

 

  

 

704

 

Payments on line of credit from LTC

  

 

—  

 

  

 

(611

)

Principal payments on mortgage loans payable

  

 

(10

)

  

 

(8

)

Issues and cancels of restricted common stock

  

 

15

 

  

 

15

 

Interest payment in form of additional LTC note payable principal

  

 

86

 

  

 

86

 

    


  


Net cash provided by financing activities

  

 

1,041

 

  

 

186

 

    


  


Increase (decrease) in cash and cash equivalents

  

 

(104

)

  

 

275

 

Cash and cash equivalents, beginning of period

  

 

1,796

 

  

 

539

 

    


  


Cash and cash equivalents, end of period

  

$

1,692

 

  

$

814

 

    


  


Supplemental disclosure of cash flow information:

                 

Interest paid

  

$

344

 

  

$

—  

 

Non-cash investing and financing activities:

                 

Assumption of mortgage loan payable

  

$

—  

 

  

$

1,190

 

Acquisition of real estate properties by deed-in-lieu of foreclosure

  

 

—  

 

  

 

1,690

 

Increase in notes payable to LTC for purchase of company from LTC

  

 

—  

 

  

 

500

 

Decrease in line of credit from LTC

  

 

4

 

  

 

—  

 

 

See accompanying notes

 

 

5


CLC HEALTHCARE, INC.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

 

1.    Basis of Presentation

 

CLC Healthcare, Inc. (the “Company”), a Nevada corporation, was incorporated on March 20, 1998, and began operations on March 25, 1998. The Company was originally a preferred stock subsidiary of LTC Properties, Inc. (“LTC”), a real estate investment trust. On September 30, 1998, concurrently with the conversion of all shares of company non-voting common stock held by LTC into voting common stock of the Company, LTC completed the spin-off of the Company common stock through a taxable dividend to holders of LTC common stock, convertible subordinated debentures and Series C Preferred Stock (the “Distribution”). Upon completion of the Distribution, the Company began operating as a separate public company.

 

The principal business of the Company is providing long-term healthcare services through the operation of nursing facilities. As of March 31, 2003 and December 31, 2002, the Company operated twenty-five nursing facilities with 2,584 licensed beds and one rehabilitation hospital with 74 licensed beds and collectively referred to herein as nursing facilities. The nursing facilities are located in six states (Georgia, Iowa, Kansas, Texas, New Mexico and Virginia). In April 2003, the Company began the process of closing one of its owned nursing facilities in New Mexico. The Company expects the nursing facility to be closed by June 2003. Also, the Company has begun the process of transferring operations of the other owned nursing facility located in New Mexico to an unrelated third-party operator. The Company expects to cease operating this nursing facility by July 1, 2003, and at that point will no longer operate in the state of New Mexico.

 

Going Concern and Management’s Plans

 

The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. Since inception, the Company has sustained significant operating losses and net losses. As shown in the consolidated financial statements, the Company incurred significant losses from operations of $4,380,000 for the three months ended March 31, 2003 and has negative working capital of $12,686,000 as of March 31, 2003, compared to negative working capital of $10,148,000 as of December 31, 2002.

 

The Company leases twenty-three of its nursing facilities from LTC and owes LTC $2,400,000 in unpaid rents under the leases as of March 31, 2003. The Company’s $10,000,000 line of credit is with LTC and had availability as of March 31, 2003, of $3,241,000. On April 17, 2003, the Company drew an additional $500,000 under the line of credit, leaving availability at $2,741,000. Should LTC call a default under the leases for nonpayment of rents, the Company could draw on the line of credit and reduce the availability to $341,000. Substantially all of the assets of the Company and its subsidiaries secure amounts under the leases, notes payable and the line of credit. These factors, among others, indicate that the Company may be unable to continue as a going concern. The consolidated financial statements do not include any adjustments relating to the recoverability and classification of liabilities that might be necessary should the Company be unable to continue as a going concern. See Note 4.—Related Parties.

 

Management recognizes that the Company’s continuation as a going concern is dependent upon its ability to generate sufficient cash flow to allow the Company to satisfy its obligations on a timely basis. As a result of the Medicare program decreasing certain reimbursements as of October 1, 2002, the Company expects its revenues will decrease in 2003 by approximately $1,600,000 without a corresponding decrease in expenses. Also, since August 18, 2001, the Company has been unable to obtain financially feasible insurance coverage for professional liability claims in the states of Texas and Florida. At the same time, the Company has experienced an increase in the number of claims filed against the Company that would have generally been covered under such insurance. Should any one or several of these claims develop into a significant obligation to the Company, the Company would not have the resources to pay such claim.

 

LTC has discussed with our Board of Directors the possible transfer of some or all of the twenty-three LTC leased facilities to other operators and our independent directors agreed, at this time, to permit LTC to solicit other operators for these facilities. LTC has committed that until June 30, 2003, and contingent on LTC reaching an agreement with another operator of any for these facilities, LTC would purchase from the Company the leasehold improvements, furniture, fixtures and equipment and pay the Company a mutually agreeable lease breakage fee for any facility leased to a new operator. LTC has also agreed to give the Company rent abatement through June 30, 2003 effective March 1, 2003.

 

6


CLC HEALTHCARE, INC.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)

(Unaudited)

 

On May 1, 2003, the Company implemented an employee retention plan, which could result in payments of approximately $1,200,000. See Note 1—Basis of Presentation—Going Concern and Management’s Plan.

 

Management would need to significantly reduce the amount of overhead of the Company should the Company and LTC agree to transfer some or all of the leased facilities to other operators. At this time, the Company is unable to make an estimate of the cost or the potential savings of such a reorganization of the Company.

 

There can be no assurances that even with a restructuring of the Company’s overhead and reduction of facilities under lease, the Company will continue to be viable.

 

Currently, the Company has no other external sources of financing and the Company has not received any other commitment with respect to any funds needed in the future. The Company does not know when it could expect to be able to access capital markets or to seek other financing and there can be no assurance that it will be able to do so at all or in amounts or on terms acceptable to the Company.

 

The consolidated financial statements included herein have been prepared by the Company without audit and in the opinion of management include all adjustments (all of which were normal and re-occurring) necessary for a fair presentation of the results of operations for the three months ended March 31, 2003, pursuant to the rules and regulations of the Securities and Exchange Commission. The accompanying consolidated financial statements include the accounts of the Company, its wholly owned subsidiaries and controlled partnerships. All significant intercompany accounts and transactions have been eliminated in consolidation. Certain reclassifications have been made to the prior periods, including the period ended March 31, 2002, to conform with the reporting for the three months ended March 31, 2003. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to such rules and regulations; however, the Company believes that the disclosures in the accompanying financial statements are adequate to make the information presented not misleading. These consolidated financial statements should be read along with the Company’s 2002 Annual Report on Form 10-K filed with the Securities and Exchange Commission. The results of operations for the three months ended March 31, 2003, are not necessarily indicative of the results for a full year.

 

2.    New Accounting Pronouncements

 

In April 2003, the Financial Accounting Standards Board issued SFAS No. 149 “Amendment of Statement 133 on Derivative Instruments and Hedging Activities.” SFAS No. 149 clarifies under what circumstances a contract with an initial net investment meets the characteristic of a derivative as discussed in SFAS No. 133 “Accounting for Derivative Instruments and Hedging Activities.” In addition, SFAS No. 149 clarifies when a derivative contains a financing component that warrants special reporting in the statement of cash flows. SFAS No. 149 is effective for contracts entered into or modified after June 30, 2003 and for hedging relationships designated after June 30, 2003. In addition, all provisions of SFAS No. 149 should be applied prospectively. At March 31, 2003, the Company had no interest rate contracts or any other derivative financial instrument outstanding.

 

The Company has adopted the disclosure requirements of SFAS No. 123, “Accounting for Stock-Based Compensation” and SFAS No. 148, “Accounting for Stock-Based Compensation —Transition and Disclosure”, but accounts for stock-based compensation using the intrinsic value method prescribed by APB Opinion No. 25.

 

7


CLC HEALTHCARE, INC.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)

(Unaudited)

 

At March 31, 2003, the Company has a stock-based employee compensation plan. The Company accounts for the plan under the recognition and measurement principles of APB Opinion No. 25, “Accounting for Stock Issued to Employees “and related Interpretations. No stock-based employee compensation is reflected in net loss, as all options granted the plan had an exercise price equal to the market value of the underlying common stock on the grant date. The following table illustrates the effect on net loss and earnings per share if the Company had applied the fair value recognition provisions of SFAS No. 123, “Accounting for Stock-Based Compensation,” to stock-based compensation.

 

    

Three Months Ended

March 31,


 
    

2003


    

2002


 

Net loss, as reported

  

$

(4,127,000

)

  

$

(2,427,000

)

Deduct: Total stock-based employee compensation expense determined under fair value based method for all awards

  

 

(1,000

)

  

 

(2,000

)

    


  


Pro forma net loss

  

$

(4,128,000

)

  

$

(2,429,000

)

    


  


Loss per share:

                 

Basic and diluted—as reported

  

$

(1.93

)

  

$

(1.13

)

    


  


Basic and diluted— pro forma

  

$

(1.93

)

  

$

(1.13

)

    


  


 

3.    Impairment Charge

 

The Company periodically performs a comprehensive evaluation of its long-lived assets. During 2002, the Company adopted SFAS No. 144 “Accounting for the Impairment or Disposal of Long-Lived Assets” and therefore calculates the impairment losses as the excess of the carrying value over the fair value of assets to be held and used, and the carrying value over the fair value. During the three months ended March 31, 2003, the Company recorded an impairment charge of $677,000 for leasehold improvements and equipment. The unanticipated decline in census and operational performance resulted in the impairment charge for the three months ended March 31, 2003.

 

4.    Related Parties

 

LTC has provided the Company with a $10,000,000 secured line of credit that bears interest at 10%, matures on April 1, 2008, and has certain restrictions as to the use of funds drawn under the agreement. The secured line of credit contains a provision for acceleration should there be a change of control of the Company. The Company is dependent upon LTC for capital and financing. As of March 31, 2003, and December 31, 2002, $6,759,000 and $5,813,000, respectively, were outstanding under the secured line of credit. During the three months ended March 31, 2003, the Company borrowed $950,000 under the line of credit. The Company has unpaid rent payable to LTC of $2,400,000 as of March 31, 2003. Subsequently, in April 2003, the Company drew an additional $500,000 under the secured line of credit. Should the Company draw on the secured line of credit to pay rents due as of March 31, 2003, the remaining availability under the loan would be $341,000.

 

For the three months ended March 31, 2003 and 2002, the Company recorded interest expense related to the secured line of credit of $147,000 and $132,000, respectively.

 

As of March 31, 2003, the Company operated 23 nursing facilities (one of which is the 74 bed rehabilitation hospital) that are owned by LTC. The 23 nursing facilities owned by LTC and leased to the Company have annual base rents totaling $3,000,000, $4,000,000, $4,750,000, $5,350,000, $5,900,000, and $6,500,000, in years 2002 through 2007. The leases contain two five-year renewal options with increases of 2% annually. These leases have a provision for acceleration should there be a change of control, as defined in the leases, of the Company. The Company recorded rent expense related to these properties of $819,000 and $763,000, respectively for the three months ended March 31, 2003 and 2002. See discussion below regarding rent abatements.

 

8


CLC HEALTHCARE, INC.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)

(Unaudited)

 

In March 2002, the Company agreed to buy from LTC a wholly owned subsidiary, LTC-Fort Tucum, Inc., for a $500,000 note bearing no interest for one year and thereafter interest at 8% annually for two years. The Company has certain rights to extend the note at its maturity. The Company used LTC-Fort Tucum to acquire two skilled nursing facilities in New Mexico, previously operated by Integrated Health Services, Inc., with a total of 97 licensed beds, in a deed-in-lieu of foreclosure transaction. These facilities are financed with debt from a REMIC pool originated by LTC. The total debt assumed by the Company was $1,172,000 and the Company began operating the facilities in June 2002. As of March 31, 2003, these mortgage loans secured by the two nursing facilities had a total outstanding principal of $1,141,000, a weighted average interest rate of 12.5% and a maturity date of April 2015. The Company recorded interest expense related the note payable of $7,000 for the three months ended March 31, 2003. In April 2003, the Company began the process of closing one of the nursing facilities and expects it to be closed by June 2003. Also, the Company has begun the process of transferring operations of the other facility to an unrelated third-party operator.

 

In December 2001, Healthcare Holdings, Inc. (“Holdings”), a wholly owned subsidiary of the Company, issued to LTC a Promissory Note (“Note”) in the face amount of $7,000,000. The Note was issued in exchange for LTC’s right to receive 1,238,076 shares of Assisted Living Concepts, Inc. (“ALC”) common stock distributed concurrently with ALC’s emergence from bankruptcy on December 31, 2001. The Note is for a term of five years and bears interest at 5.0% compounded annually and accruing to the principal balance plus interest at 2.0% on the original principal of $7,000,000 payable in cash annually. The Note is a full recourse obligation of Holdings and is secured by all the assets owned now or in the future by Holdings and contains a provision for acceleration should there be a change of control of Holdings or the Company. As of March 31, 2003, the Note had a principal balance of $7,436,000. The Company recorded interest expense related the Note of $120,000 for the three months ended March 31, 2003.

 

The Company has agreed to allow LTC to seek other operators for some or all of the twenty-three leased nursing facilities. LTC has given the Company rent concessions on all rents for the period of March 1, 2003, through June 1, 2003, as consideration for allowing LTC to seek new operators on some or all of the twenty-three nursing facilities leased from LTC. See Note 1—Basis of Presentation.

 

5.    Debt and Equity Securities

 

At March 31, 2003, Holdings owned $1,225,000 face amount of ALC new Senior Secured Notes and $578,000 new Junior Secured Notes, which the Company recorded at management’s estimate of the fair market value of $1,417,000. During the three months ended March 31, 2003, the Company received an additional $11,000 of ALC Junior Secured Notes as interest in-kind, respectively. Unrealized holding loss on change in the fair value of the investment of $4,000 and $3,000 respectively, is included in the comprehensive loss for the three months ended March 31, 2003 and 2002. Subsequent to March 31, 2003, Holdings sold to LTC $500,000 face value of ALC Senior Secured Notes for $500,000 plus accrued interest. The proceeds of which were used to fund Company operations.

 

As of March 31, 2003, and December 31, 2002, the Company owned 1,452,794 shares of ALC’s 6,500,000 common shares outstanding or 22.4% of the total ALC outstanding common stock. In accordance with APB Opinion No. 18, “The Equity Method of Accounting for Investments in Common Stock” (“APB 18”), the Company is recording its proportionate share of the equity and earnings reported by ALC. At December 31, 2001, the Company’s carrying value of its investment in ALC’s common stock was $3,739,000. At December 31, 2001, 22.4% of ALC’s $32,799,000 equity was $7,413,000. The difference is being accreted over 40 years, which is management’s estimate of the useful lives of ALC’s non-current assets. Also, the Company records its share of ALC’s earnings and losses, based on the 22.4% common stock ownership. During the three months ended March 31, 2003, the Company recorded $22,000 of equity and $231,000 of income related to the Company’s investment in ALC’s common stock. During the three months ended March 31, 2002, the Company recorded $23,000 of equity and $324,000 of losses related to the Company’s investment in ALC’s common stock.

 

9


CLC HEALTHCARE, INC.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)

(Unaudited)

 

6.    Long-term Debt

 

LTC has provided the Company with a $10,000,000 secured line of credit that bears interest at 10% and matures in April 1, 2008, as amended. See Note 4—Related Parties. As of March 31, 2003, and December 31, 2002, $6,759,000 and $5,813,000, respectively was outstanding under the secured line of credit.

 

At March 31, 2003, and 2002, the Company had two notes payable due to LTC in the total amount of $7,936,000 and $7,850,000, respectively. See Note 4—Related Parties. During the three months ended March 31, 2003, and 2002, the Company recorded interest expense of $127,000 and $121,000, respectively, on these notes, $86,000 and $86,000, respectively, of which was in the form of additional principal.

 

At March 31, 2003, and December 31, 2002, the Company had total outstanding mortgage loans of $1,141,000 and $1,150,000, respectively, with a weighted average interest rate of 12.5% and a maturity date of April 2015. See Note 4—Related Parties.

 

7.    Contingencies

 

The Company is required, as the lessee of the properties we operate, to secure adequate comprehensive liability insurance. Since March 18, 2001, the Company has been able to purchase coverage for general and professional liability on a claims-made basis in every state except for Texas and Florida. The Company ceased all operations in Florida in August 2001. The Company has notified LTC, its landlord in the state of Texas, regarding this lapse in coverage. The Company has developed a reserve for general and professional liability risks, based on historical data, related to the nursing facilities in Texas and Florida, which currently carry no general and professional liability insurance. At March 31, 2003, and December 31, 2002, the Company had a reserve for general and professional liability risks of $13,234,000 and $11,946,000, respectively. These reserves include the Company’s estimate of potential uninsured exposure in Texas and Florida and the Company’s estimate of exposure outside of the insured policy coverage and are included in accrued self-insurance risk of the accompanying balance sheets.

 

The Company is a party to various legal proceedings related to operations of its nursing facilities. The Company analyzes all claims against it and vigorously defends those claims. The Company attempts to resolve all claims in a manner that is in the best interest of the Company. Given the current litigation environment and unpredictability of jury trials, the existing claims could develop in a way which may present a material adverse affect on the Company’s financial position, results of operations or liquidity. Based on the Company’s insurance for those claims for which insurance exists and the Company’s allowance for general and professional liability risk in an amount determined for reported claims and the incurred but not reported claims, management believes, at this time, that the existing claims do not present a material adverse affect on the Company’s financial position or results of operations, however, such claims could have a material adverse effect on liquidity. Such analysis and allowance is based on past experiences and estimates, while management, at this time, believes the provision for any loss is adequate, the ultimate liability may be in excess of or less than the amounts recorded.

 

The Texas Health and Safety Code § 242.0372 requires as a condition of licensure for a nursing facility to maintain professional liability insurance. The statute takes effect September 1, 2003, and requires that the coverage limits be in the minimum amount of $1,000,000 per occurrence and $3,000,000 aggregate; be written on a claims made basis; be issued by either an admitted insurer, the Texas Medical Liability Insurance Underwriting Association or an eligible surplus lines insurer. The Company interprets the Texas Health and Safety Code coverage limits as a per facility requirement and the Company currently operates seven facilities in the state of Texas. The Texas Legislature went into session at the beginning of 2003 and is reviewing this statute.

 

Currently, the Company has been unable to obtain financially feasible professional liability insurance coverage in the State of Texas. The Company is unable at this point in time to determine if in the future it will be able to obtain professional liability insurance coverage, which meets the conditions of licensure effective September 1, 2003.

 

If the legislature does not repeal or amend the current professional liability insurance requirements as a condition of licensure, it is possible that the state could revoke the licenses of the facilities located in Texas and the Company could no longer operate the facilities and the Company would be in default of its leases with LTC and as the landlord LTC, could impose all

 

10


CLC HEALTHCARE, INC.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)

(Unaudited)

 

of its rights and remedies under the leases including the potential termination the leases (resulting in the loss to the Company of the ability to operate the facilities) and assertion of leasehold damages against the Company.

 

If the Company were not able to obtain professional liability insurance coverage in the State of Texas and, as a result, could no longer operate its Texas facilities, it would have a material adverse effect on the Company’s financial position, results of operations and liquidity.

 

8.    Stockholders’ Deficit

 

During the three months ended March 31, 2003 and 2002, the Company recorded compensation expense related to restricted stock of $16,000 and $15,000, respectively.

 

9.    Concentration of Credit Risks

 

The Company has significant accounts receivable whose collectibility or realizability is dependent upon the performance of certain government programs, primarily Medicare and Medicaid. The Company believes that an adequate provision has been made for the possibility of accounts receivable proving uncollectible and continually monitors and adjusts these reserves as necessary.

 

As of March 31, 2003, the Company’s investment of $3,095,000 in ALC’s common stock and $1,041,000 Senior Secured Notes and $376,000 Junior Secured Notes represented 14%, 5%, and 2%, respectively, of the Company’s total assets.

 

The Company’s financial position, results of operations and liquidity could be adversely affected by financial difficulties experienced by ALC, including bankruptcy, insolvency or general downturn in business. The following table contains summary information for ALC that was extracted from public reports on file with the Securities and Exchange Commission. ALC is a publicly traded company, and as such is subject to the filing requirements of the Securities and Exchange Commission.

 

              

Three Months Ended

March 31,


 
    

March 31,

2003


  

December 31,

2002


  

2003


  

2002


 
    

(Unaudited)

       

(Unaudited)

      

ALC

                             

Total assets

  

$

214,121

  

$

216,040

  

 

N/A

  

 

N/A

 

Total debt

  

$

160,046

  

$

162,592

  

 

N/A

  

 

N/A

 

Total stockholders’ equity

  

$

29,966

  

$

28,385

  

 

N/A

  

 

N/A

 

Total revenues

  

 

N/A

  

 

N/A

  

$

41,144

  

$

37,014

 

Net income (loss) before taxes

  

 

N/A

  

 

N/A

  

$

901

  

$

(1,404

)

Net income (loss)

  

 

N/A

  

 

N/A

  

$

1,031

  

$

(1,450

)

 

10.    Income Taxes

 

SFAS No. 109 requires the reduction of the deferred tax assets by a valuation allowance if, based on the weight of available evidence, it is more likely than not that a portion or all of the deferred tax asset will not be realized. Sufficient taxable income must be generated in future years to realize the tax benefit associated with the net deferred tax asset. The Company believes that sufficient doubt exists as to whether future taxable income will be sufficient to realize such tax benefits and, accordingly, a valuation allowance was established against the deferred tax asset and no tax benefit was recorded.

 

During the three months ended March 31, 2002, the Company recorded state income tax expense $125,000, respectively related to the sale of wholly owned subsidiaries to LTC in 2001. The Company recorded no income tax expense in the three months ended March 31, 2003.

 

11


Item2.    MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

Operating Results

 

Three Months Ended March 31, 2003, Compared to the Three Months Ended March 31, 2002

 

The total revenues for the three months ended March 31, 2003, and 2002, were $22,813,000 and $22,636,000, respectively. Net resident revenue decreased $728,000 for the three months ended March 31, 2003, as compared to the three months ended March 31, 2002. The net resident revenue for the twenty-four same store nursing facilities for the three months ended March 31, 2003, decreased $297,000 as a result of lower resident census during the same three months ended March 31, 2002. Also, the Company operated two additional nursing facilities during the three months ended March 31, 2003, which provided $661,000 of net resident revenue. Subsequent to March 31, 2002, the Company ceased operating two nursing facilities, which had provided $1,092,000 of net resident revenue for the three months ended March 31, 2002. Interest and other income were $233,000 and $328,000 for the three months ended March 31, 2003, and March 31, 2002, respectively. The decrease in interest and other income is primarily the result of less ancillary services income due to lower Medicare resident census during the three months ended March 31, 2003, as compared to the three months ended March 31, 2002.

 

For both the three months ended March 31, 2003 and 2002, salaries and benefits were $16,697,000 and $16,776,000, respectively. Salaries and benefits for the same store nursing facilities increased $462,000 for the three months ended March 31, 2003, as compared to the same three months ended March 31, 2002. The increase is a result of increased contact labor utilization and increased benefits costs for the three months ended March 31, 2003. The two additional nursing facilities incurred $470,000 of salaries and benefits in the three months ended March 31, 2003. Two nursing facilities, which the Company has ceased operating, had incurred $1,011,000 of salaries and benefits for the three months ended March 31, 2002.

 

Supplies expense were $2,472,000 and $2,544,000 for the three months ended March 31, 2003 and 2002, respectively. Supplies expense for the twenty-three same store nursing facilities decreased $24,000 for the three months ended March 31, 2003, as compared to the three months ended March 31, 2002. The two additional nursing facilities incurred $47,000 of supplies expense for the three months ended March 31, 2003. The two nursing facilities, which the Company has ceased operating, had incurred $95,000 of supplies expense for the three months ended March 31, 2002.

 

For both three months ended March 31, 2003 and 2002, twenty-three of the nursing facilities operated by the Company were leased from LTC. The rent expense for the three months ended March 31, 2003 and 2002, was $819,000 and $763,000, respectively, under the related operating leases with LTC. The Company received rent abatement of $409,000 from LTC for March 2003 as consideration for the Company allowing LTC search for other operators on some or all of the twenty-three nursing facilities leased from LTC. The Company did not utilize the straight-line method of recording rent during the three months ended March 31, 2002, which would have increased the rent expense of the three months to $1,228,000.

 

Interest expense on notes payable to LTC for the three months ended March 31, 2003, and March 31, 2002, was $127,000 and $121,000, respectively.

 

For the three months ended March 31, 2003 and 2002, the Company had interest expense on the secured line of credit with LTC of $147,000 and $132,000, respectively. The increase in interest expense on the secured line of credit with LTC was a result of a higher average outstanding balance on the secured line of credit with LTC for the three months ended March 31, 2003, as compared to the three months ended March 31, 2002. The average outstanding balance on the line of credit with LTC for the three months ended March 31, 2003 and 2002, were $5,972,000 and $5,356,000, respectively.

 

For the three months ended March 31, 2003 and 2002, the Company recorded a provision for bad debts of $221,000 and $197,000, respectively. Bad debt expense for the twenty-three same store nursing facilities increased $27,000 for the three months ended March 31, 2003, as compared to the three months ended March 31, 2002. The two additional nursing facilities incurred $26,000 of bad debt expense for the three months ended March 31, 2003. Also, the two nursing facilities, which the Company has ceased operating, had incurred $29,000 of bad debt expense for the three months ended March 31, 2002.

 

In the three months ended March 31, 2003, the Company recorded an impairment charge of $677,000 related to long-lived assets, which the Company has determined that the carrying amount of these assets exceeds the fair value using estimated undiscounted cash flows.

 

12


 

Other operating and administrative expenses for the three months ended March 31, 2003 and 2002, were $3,019,000 and $2,874,000, respectively. The twenty-three same store nursing facilities other operating and administrative expense increased $359,000 for the three months ended March 31, 2003, as compared to the three months ended March 31, 2002. The increase is primarily the result of the increased legal expenses related to its defense of general and professional liability claims during the three months ended March 31, 2003. The two additional nursing facilities incurred $167,000 of other operating and administrative expenses for the three months ended March 31, 2003. The two nursing facilities which the Company has ceased operating had incurred $381,000 of other operating and administrative expenses for the three months ended March 31, 2002.

 

During the three months ended March 31, 2002, the Company recorded state income tax expense $125,000, respectively related to the sale of wholly owned subsidiaries to LTC in 2001.

 

No benefit for income taxes was recorded for the three months ended March 31, 2003 and 2002, since the Company believes that it is more likely than not that future taxable income will not be sufficient to realize tax benefits associated with net operating loss carry-forwards.

 

Liquidity and Capital Resources

 

LTC has provided the Company with a $10,000,000 secured line of credit that bears interest at an annual rate of 10% and matures on April 1, 2008. The line of credit does not allow the Company to draw funds under the agreement to pay any claim resulting from an uninsured loss arising as a result of a claim for general or professional liability. Additionally, the line of credit requires the Company to submit a certification from an officer of the Company at the time of a funding request that such requested funds will not be used in violation of this provision. As of March 31, 2003, the Company had borrowings outstanding under the secured line of credit of $6,759,000. The Company is dependent upon LTC for capital and financing. The Company has unpaid rent payable to LTC of $2,400,000 as of March 31, 2003. Subsequently, in April 2003, the Company drew an additional $500,000 under the secured line of credit. Should the Company draw on the secured line of credit to pay rents due as of March 31, 2003, the remaining availability under the loan would be $341,000.

 

At March 31, 2003, the Company had cash and cash equivalents of $1,692,000, of which $1,561,000 was restricted.

 

Net cash used by operating activities for the three months ended March 31, 2003, was $1,116,000. The Company had a net loss for the three months ended March 31, 2003, of $4,127,000, which is the primary use of cash during the three months ended March 31, 2003.

 

Net cash used in investing activities for the three months ended March 31, 2003, was $29,000. The Company used $29,000 of cash for equipment and improvements for the three months ended March 31, 2003, which was related primarily to the purchase of equipment and leasehold improvements associated with the Company’s management of the nursing operations and the nursing facilities.

 

Net cash provided by financing activities for the three months ended March 31, 2003, was $1,041,000. During the three months ended March 31, 2003, the Company utilized borrowings under the secured line of credit of $950,000 to fund the working capital requirements of the nursing facilities operated by the Company. The Company made payments of $10,000 on mortgage loans during the three months ended March 31, 2003. The Company made interest payments on notes payable to LTC in the form of additional principal of $86,000 during the three months ended March 31, 2003. The Company had net issues and cancellations of restricted stock of $15,000 during the three months ended March 31, 2003.

 

As discussed in Note 7—Contingencies, the Company has a significant reserve for uninsured general and profession liability claims. While management believes, at this time, that the existing claims do not present a material adverse affect on the Company’s financial position or results of operations, such claims could have a material adverse effect on the Company’s liquidity. The analysis and recorded allowance for these claims is based on past experience and estimates and while management, at this time, believes their estimates of allowances are adequate, the ultimate liability may be in excess of or less than the amounts recorded.

 

The Company anticipates that cash flow from operations and borrowings under its line of credit will be adequate to meet its short-term liquidity requirements. The ability of the Company to satisfy its long term liquidity requirements will be dependent upon its future performance, which will be subject to prevailing economic conditions and to financial, business, economic and other factors beyond the our control. There can be no assurance that future healthcare legislation or other efforts by governmental and private payors to reduce healthcare costs will not have a material adverse effect on the

 

13


Company’s results of operations, liquidity and financial position. Currently, the Company has no other external sources of financing and the Company has not received any other commitment with respect to any funds needed in the future. On May 1, 2003, the Company implemented an employee retention plan, which could result in payments of approximately $1,200,000.

 

The Company does not know when it could expect to be able to access capital markets or to seek other financing and there can be no assurance that it will be able to do so at all or in amounts or on terms acceptable to the Company.

 

New Accounting Pronouncements Critical Accounting Policies

 

In April 2003, the Financial Accounting Standards Board issued SFAS No. 149 “Amendment of Statement 133 on Derivative Instruments and Hedging Activities.” SFAS No. 149 clarifies under what circumstances a contract with an initial net investment meets the characteristic of a derivative as discussed in SFAS No. 133 “Accounting for Derivative Instruments and Hedging Activities.” In addition, SFAS No. 149 clarifies when a derivative contains a financing component that warrants special reporting in the statement of cash flows. SFAS No. 149 is effective for contracts entered into or modified after June 30, 2003 and for hedging relationships designated after June 30, 2003. In addition, all provisions of SFAS No. 149 should be applied prospectively. At March 31, 2003, the Company had no interest rate contracts or any other derivative financial instrument outstanding.

 

For further discussion of the Company’s critical accounting policies, see the Company’s Annual Report filed on Form 10-K for the year ended December 31, 2002.

 

Statement Regarding Forward Looking Disclosure

 

Certain information contained in this report includes forward looking statements, which can be identified by the use of forward looking terminology such as “may”, “will”, “expect”, “should” or comparable terms or negatives thereof. These statements involve risks and uncertainties that could cause actual results to differ materially from those described in the statements. These risks and uncertainties include (without limitation) the following: the effect of economic and market conditions and changes in interest rates, government policy relating to the health care industry including changes in reimbursement levels under the Medicare and Medicaid programs, changes in reimbursement by other third party payors, the financial strength of the Company’s facilities as it affects our continuing ability to meet the obligations under the terms of the our agreements with its lenders.

 

Item 3.    QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

Not applicable.

 

Item 4.    CONTROLS AND PROCEDURES

 

The Chief Executive Officer and the Chief Financial Officer of the Company (its principal executive officer and principal financial officer, respectively) have concluded, based on their evaluation as of a date within 90 days prior to the date of the filing of this report, that the Company’s disclosure controls and procedures are effective to ensure that information required to be disclosed by the Company in the reports filed or submitted by it under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and include controls and procedures designed to ensure that information required to be disclosed by the Company in such reports is accumulated and communicated to the Company’s management, including the Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

 

There were no significant changes in the Company’s internal controls or in other factors that could significantly affect these controls subsequent to the date of such evaluation.

 

14


 

PART II

 

OTHER INFORMATION

 

Item 6.    Exhibits and Reports on Form 8-K

 

  (a)   Exhibits

 

In accordance with Item 601(b)(4)(iii) of Regulation S-K, certain instruments pertaining to Registrant’s long-term debt have not been filed; copies thereof will be furnished to the Securities and Exchange Commission upon request.

 

10.1 Assisted Living Concepts, Inc. December 31, 2002 Form 10-K

 

99.1 Certification by Alan J. Zampini pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 

99.2 Certification by Andrew M. Kerr pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

 

  (b)   Reports on Form 8-K

 

On April 14, 2003, the Company filed a Current Report on Form 8-K dated April 10, 2003, reporting that Messrs. Andre C. Dimitriadis, Christopher T. Ishikawa, and Peter Lyew resigned as Chief Executive Officer and President, Chief Operating Officer and Vice-President and Director of Taxes, respectively of Registrant. Mr. Dimitriadis remains Chairman of the Board and Mr. Ishikawa remains a Board member of the Registrant.

 

Mr. Alan J. Zampini was elected Chief Executive Officer of Registrant by the Board of Directors on the same day.

 

15


SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

       

CLC HEALTHCARE, INC.
Registrant

Dated:  May 14, 2003

     

By:

 

/s/    ANDREW M. KERR        


               

Andrew M. Kerr
Chief Financial Officer

 

16


Form 10-Q Section 302 Certification

 

CERTIFICATION

 

I, Alan J. Zampini, certify that:

 

  1.   I have reviewed this quarterly report on Form 10-Q of CLC Healthcare, Inc.;

 

  2.   Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;

 

  3.   Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report;

 

  4.   The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for the registrant and we have:

 

  a)   designed such disclosure controls and procedures to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared;

 

  b)   evaluated the effectiveness of the registrant’s disclosure controls and procedures as of a date within 90 days prior to the filing date of this quarterly report (the “Evaluation Date”); and

 

  c)   presented in this quarterly report our conclusions about the effectiveness of the disclosure controls and procedures based on our evaluation as of the Evaluation Date;

 

  5.   The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent function):

 

  a)   all significant deficiencies in the design or operation of internal controls which could adversely affect the registrant’s ability to record, process, summarize and report financial data and have identified for the registrant’s auditors any material weaknesses in internal controls; and

 

  b)   any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls; and

 

  6.   The registrant’s other certifying officers and I have indicated in this quarterly report whether or not there were significant changes in internal controls or in other factors that could significantly affect internal controls subsequent to the date of our most recent evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses.

 

Date:  May 14, 2003

     

/s/    ALAN J. ZAMPINI         


           

Alan J. Zampini
Chief Executive Officer


Form 10-Q Section 302 Certification

 

CERTIFICATION

 

I, Andrew M. Kerr, certify that:

 

  1.   I have reviewed this quarterly report on Form 10-Q of CLC Healthcare, Inc.;

 

  2.   Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;

 

  3.   Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report;

 

  4.   The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for the registrant and we have:

 

  d)   designed such disclosure controls and procedures to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared;

 

  e)   evaluated the effectiveness of the registrant’s disclosure controls and procedures as of a date within 90 days prior to the filing date of this quarterly report (the “Evaluation Date”); and

 

  f)   presented in this quarterly report our conclusions about the effectiveness of the disclosure controls and procedures based on our evaluation as of the Evaluation Date;

 

  5.   The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent function):

 

  c)   all significant deficiencies in the design or operation of internal controls which could adversely affect the registrant’s ability to record, process, summarize and report financial data and have identified for the registrant’s auditors any material weaknesses in internal controls; and

 

  d)   any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls; and

 

  6.   The registrant’s other certifying officers and I have indicated in this quarterly report whether or not there were significant changes in internal controls or in other factors that could significantly affect internal controls subsequent to the date of our most recent evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses.

 

Date:  May 14, 2003

     

/s/    ANDREW M. KERR         


           

Andrew M. Kerr
Chief Financial Officer